Brief: Xoma Enters Into Agreement To Acquire Kinnate Biopharma

Xoma Royalty

16/02/2024 14:27

Feb 16 (Reuters) - Kinnate Biopharma Inc  KNTE.O :
    * XOMA ENTERS INTO AGREEMENT TO ACQUIRE KINNATE
BIOPHARMA FOR
BETWEEN $2.3352 AND $2.5879 IN CASH PER SHARE PLUS A CONTINGENT
VALUE RIGHT
    * KINNATE'S BOARD UNANIMOUSLY APPROVED MERGER AGREEMENT
    * IMMEDIATELY FOLLOWING CLOSING OF TENDER OFFER, KINNATE
WILL
MERGE WITH A SUBSIDIARY OF XOMA

Source text for Eikon:  ID:nGNX7Ytzqq 
Further company coverage:  KNTE.O 

 ((Reuters.Briefs@thomsonreuters.com;))